Sandra Schoors
Partner @ VIVES Funds
Sandra Schoors is a Series B investor at VIVES Funds focused on Medical and Health Care. Sandra Schoors, partner at VIVES Partners.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sandra Schoors invests in
Stages Sandra Schoors invests in
Countries Sandra Schoors invests in
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Health Diagnostics 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nuclidium
|
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $33.6M / Series B / May 28, 2026 | |
|
Nuclidium
|
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $131.8M / Series B / Jul 10, 2025 |
Co-Investors
About VIVES Funds
VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact.
VIVES Funds Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Sandra Schoors
Partner
|
|||
Yannick Vancoppenolle
Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sandra Schoors invest in?
Sandra Schoors invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sandra Schoors last invest?
The most recent investment recorded for Sandra Schoors closed in May 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
